Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 78 entries
Sorted by: Best Match Show Resources per page
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions.

International journal of pharmaceutical compounding

Allen LV.
PMID: 28339375
Int J Pharm Compd. 2016 Sep-Oct;20(5):399-404.

Ophthalmic preparations are used to treat allergies, bacterial and viral infections, glaucoma, and numerous other eye conditions. When the eye's natural defensive mechanisms are compromised or overcome, an ophthalmic preparation, in a solution, suspension, or ointment form, may be...

Cite
Allen LV. Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions. Int J Pharm Compd. 2016;20(5):399-404
Allen, L. V. (2016). Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions. International journal of pharmaceutical compounding, 20(5), 399-404.
Allen, Loyd V. "Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions." International journal of pharmaceutical compounding vol. 20,5 (2016): 399-404.
Allen LV. Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions. Int J Pharm Compd. 2016 Sep-Oct;20(5):399-404. PMID: 28339375.
Copy Download .nbib Format: NLM
Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community.

The open ophthalmology journal

Kashiwagi K.
PMID: 20556196
Open Ophthalmol J. 2010 Apr 28;4:7-11. doi: 10.2174/1874364101004010007.

PURPOSE: To investigate changes in the trend of anti-glaucoma ophthalmic solutions in 2000-2008 in a Japanese local community.MATERIALS AND METHODS: The subjects of this study were patients with glaucoma who were registered in the database of the glaucoma clinic...

Cite
Kashiwagi K. Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community. Open Ophthalmol J. 2010;4:7-11doi: 10.2174/1874364101004010007.
Kashiwagi, K. (2010). Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community. The open ophthalmology journal, 47-11. https://doi.org/10.2174/1874364101004010007
Kashiwagi, Kenji. "Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community." The open ophthalmology journal vol. 4 (2010): 7-11. doi: https://doi.org/10.2174/1874364101004010007
Kashiwagi K. Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community. Open Ophthalmol J. 2010 Apr 28;4:7-11. doi: 10.2174/1874364101004010007. PMID: 20556196; PMCID: PMC2878975.
Copy Download .nbib Format: NLM
In vivo comparative study of ocular vasodilation, a relative indicator of hyperemia, in guinea pigs following treatment with bimatoprost ophthalmic solutions 0.01% and 0.03%.

Clinical ophthalmology (Auckland, N.Z.)

Ogundele AB, Earnest D, McLaughlin MA.
PMID: 20689777
Clin Ophthalmol. 2010 Jul 30;4:649-52. doi: 10.2147/opth.s10444.

OBJECTIVE: The objective of this in vivo study was to compare the incidence of vasodilation in guinea pigs following topical administration of bimatoprost ophthalmic solutions 0.01% and 0.03%.METHODS: The study comprised 20 guinea pigs assigned to 2 treatment groups...

Cite
Ogundele AB, Earnest D, McLaughlin MA. In vivo comparative study of ocular vasodilation, a relative indicator of hyperemia, in guinea pigs following treatment with bimatoprost ophthalmic solutions 0.01% and 0.03%. Clin Ophthalmol. 2010;4:649-52doi: 10.2147/opth.s10444.
Ogundele, A. B., Earnest, D., & McLaughlin, M. A. (2010). In vivo comparative study of ocular vasodilation, a relative indicator of hyperemia, in guinea pigs following treatment with bimatoprost ophthalmic solutions 0.01% and 0.03%. Clinical ophthalmology (Auckland, N.Z.), 4649-52. https://doi.org/10.2147/opth.s10444
Ogundele, Abayomi B, et al. "In vivo comparative study of ocular vasodilation, a relative indicator of hyperemia, in guinea pigs following treatment with bimatoprost ophthalmic solutions 0.01% and 0.03%." Clinical ophthalmology (Auckland, N.Z.) vol. 4 (2010): 649-52. doi: https://doi.org/10.2147/opth.s10444
Ogundele AB, Earnest D, McLaughlin MA. In vivo comparative study of ocular vasodilation, a relative indicator of hyperemia, in guinea pigs following treatment with bimatoprost ophthalmic solutions 0.01% and 0.03%. Clin Ophthalmol. 2010 Jul 30;4:649-52. doi: 10.2147/opth.s10444. PMID: 20689777; PMCID: PMC2915847.
Copy Download .nbib Format: NLM
Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models.

Asia Pacific allergy

Tamura T.
PMID: 22701861
Asia Pac Allergy. 2012 Apr;2(2):115-21. doi: 10.5415/apallergy.2012.2.2.115. Epub 2012 Apr 23.

BACKGROUND: Olopatadine hydrochloride ophthalmic solutions are treated for allergic conjunctival diseases that are a selective histamine H1 receptor antagonist and an inhibitor of the release of mediators including histamine from the human mast cells. Substance P (SP) levels are...

Cite
Tamura T. Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models. Asia Pac Allergy. 2012;2(2):115-21doi: 10.5415/apallergy.2012.2.2.115.
Tamura, T. (2012). Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models. Asia Pacific allergy, 2(2), 115-21. https://doi.org/10.5415/apallergy.2012.2.2.115
Tamura, Tadafumi. "Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models." Asia Pacific allergy vol. 2,2 (2012): 115-21. doi: https://doi.org/10.5415/apallergy.2012.2.2.115
Tamura T. Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models. Asia Pac Allergy. 2012 Apr;2(2):115-21. doi: 10.5415/apallergy.2012.2.2.115. Epub 2012 Apr 23. PMID: 22701861; PMCID: PMC3345324.
Copy Download .nbib Format: NLM
Antiglaucoma drugs: The role of preservative-free formulations.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society

Bagnis A, Papadia M, Scotto R, Traverso CE.
PMID: 23960953
Saudi J Ophthalmol. 2011 Oct;25(4):389-94. doi: 10.1016/j.sjopt.2011.08.004. Epub 2011 Aug 28.

Hypersensitive reactions to eyedrops are a common finding in clinical practice and represent a frequent cause of discontinuation of the therapy. Moreover, experimental and clinical studies show that long term use of topical drugs may induce ocular surface changes...

Cite
Bagnis A, Papadia M, Scotto R, et al. Antiglaucoma drugs: The role of preservative-free formulations. Saudi J Ophthalmol. 2011;25(4):389-94doi: 10.1016/j.sjopt.2011.08.004.
Bagnis, A., Papadia, M., Scotto, R., & Traverso, C. E. (2011). Antiglaucoma drugs: The role of preservative-free formulations. Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society, 25(4), 389-94. https://doi.org/10.1016/j.sjopt.2011.08.004
Bagnis, Alessandro, et al. "Antiglaucoma drugs: The role of preservative-free formulations." Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society vol. 25,4 (2011): 389-94. doi: https://doi.org/10.1016/j.sjopt.2011.08.004
Bagnis A, Papadia M, Scotto R, Traverso CE. Antiglaucoma drugs: The role of preservative-free formulations. Saudi J Ophthalmol. 2011 Oct;25(4):389-94. doi: 10.1016/j.sjopt.2011.08.004. Epub 2011 Aug 28. PMID: 23960953; PMCID: PMC3729930.
Copy Download .nbib Format: NLM
Annual direct cost of dry eye in Japan.

Clinical ophthalmology (Auckland, N.Z.)

Mizuno Y, Yamada M, Shigeyasu C.
PMID: 22654503
Clin Ophthalmol. 2012;6:755-60. doi: 10.2147/OPTH.S30625. Epub 2012 May 16.

BACKGROUND: This study was performed to estimate the annual direct cost incurred by dry eye patients, which includes expenses for treatment and drugs, as well as the cost of punctal plugs.METHODS: The study group consisted of 118 dry eye...

Cite
Mizuno Y, Yamada M, Shigeyasu C. Annual direct cost of dry eye in Japan. Clin Ophthalmol. 2012;6:755-60doi: 10.2147/OPTH.S30625.
Mizuno, Y., Yamada, M., & Shigeyasu, C. (2012). Annual direct cost of dry eye in Japan. Clinical ophthalmology (Auckland, N.Z.), 6755-60. https://doi.org/10.2147/OPTH.S30625
Mizuno, Yoshinobu, et al. "Annual direct cost of dry eye in Japan." Clinical ophthalmology (Auckland, N.Z.) vol. 6 (2012): 755-60. doi: https://doi.org/10.2147/OPTH.S30625
Mizuno Y, Yamada M, Shigeyasu C. Annual direct cost of dry eye in Japan. Clin Ophthalmol. 2012;6:755-60. doi: 10.2147/OPTH.S30625. Epub 2012 May 16. PMID: 22654503; PMCID: PMC3363310.
Copy Download .nbib Format: NLM
Changes of tear film lipid layer thickness by 3% diquafosol ophthalmic solutions in patients with dry eye syndrome.

International journal of ophthalmology

Kang DH, Lee YW, Hwang KY, Koh KM, Kwon YA, Kim BY, Song SW, Kim KY.
PMID: 31637190
Int J Ophthalmol. 2019 Oct 18;12(10):1555-1560. doi: 10.18240/ijo.2019.10.06. eCollection 2019.

AIM: To evaluate the quantitatively changes in lipid layer thickness (LLT) when 3% diquafosol eye drop is used for dry eye patients using the tear film interferometer.METHODS: A total 124 participants (32 males, 92 females; mean age, 28.9y) diagnosed...

Cite
Kang DH, Lee YW, Hwang KY, et al. Changes of tear film lipid layer thickness by 3% diquafosol ophthalmic solutions in patients with dry eye syndrome. Int J Ophthalmol. 2019;12(10):1555-1560doi: 10.18240/ijo.2019.10.06.
Kang, D. H., Lee, Y. W., Hwang, K. Y., Koh, K. M., Kwon, Y. A., Kim, B. Y., Song, S. W., & Kim, K. Y. (2019). Changes of tear film lipid layer thickness by 3% diquafosol ophthalmic solutions in patients with dry eye syndrome. International journal of ophthalmology, 12(10), 1555-1560. https://doi.org/10.18240/ijo.2019.10.06
Kang, Dong-Hyun, et al. "Changes of tear film lipid layer thickness by 3% diquafosol ophthalmic solutions in patients with dry eye syndrome." International journal of ophthalmology vol. 12,10 (2019): 1555-1560. doi: https://doi.org/10.18240/ijo.2019.10.06
Kang DH, Lee YW, Hwang KY, Koh KM, Kwon YA, Kim BY, Song SW, Kim KY. Changes of tear film lipid layer thickness by 3% diquafosol ophthalmic solutions in patients with dry eye syndrome. Int J Ophthalmol. 2019 Oct 18;12(10):1555-1560. doi: 10.18240/ijo.2019.10.06. eCollection 2019. PMID: 31637190; PMCID: PMC6796099.
Copy Download .nbib Format: NLM
Microbial Contamination and Antimicrobial Resistance in Use of Ophthalmic Solutions at the Department of Ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Tamrat L, Gelaw Y, Beyene G, Gize A.
PMID: 31178944
Can J Infect Dis Med Microbiol. 2019 Apr 15;2019:5372530. doi: 10.1155/2019/5372530. eCollection 2019.

BACKGROUND: Eye drops are most frequently used medications in ophthalmology. The carriage of pathogenic organisms to eyes through the agency of eye drops has presented a serious problem for several decades. The objective of this study was to determine...

Cite
Tamrat L, Gelaw Y, Beyene G, et al. Microbial Contamination and Antimicrobial Resistance in Use of Ophthalmic Solutions at the Department of Ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019:5372530doi: 10.1155/2019/5372530.
Tamrat, L., Gelaw, Y., Beyene, G., & Gize, A. (2019). Microbial Contamination and Antimicrobial Resistance in Use of Ophthalmic Solutions at the Department of Ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 20195372530. https://doi.org/10.1155/2019/5372530
Tamrat, Lemlem, et al. "Microbial Contamination and Antimicrobial Resistance in Use of Ophthalmic Solutions at the Department of Ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia." The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale vol. 2019 (2019): 5372530. doi: https://doi.org/10.1155/2019/5372530
Tamrat L, Gelaw Y, Beyene G, Gize A. Microbial Contamination and Antimicrobial Resistance in Use of Ophthalmic Solutions at the Department of Ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia. Can J Infect Dis Med Microbiol. 2019 Apr 15;2019:5372530. doi: 10.1155/2019/5372530. eCollection 2019. PMID: 31178944; PMCID: PMC6501278.
Copy Download .nbib Format: NLM
Scleral growth stunting via sub-Tenon injection of cross-linking solutions in live rabbits.

The British journal of ophthalmology

Hoang QV, Wen Q, Paik DC, Chun YY, Silverman R, Nagasaki T, Trokel SL, Zyablitskaya M.
PMID: 34670748
Br J Ophthalmol. 2021 Oct 20; doi: 10.1136/bjophthalmol-2021-319427. Epub 2021 Oct 20.

BACKGROUND: Scleral cross-linking is a potential method to inhibit axial elongation of the eye, preventing the progression of pathological myopia. Formaldehyde releasers, which are common preservatives found in cosmetics and ophthalmic solutions, have been shown to be not only...

Cite
Hoang QV, Wen Q, Paik DC, et al. Scleral growth stunting via sub-Tenon injection of cross-linking solutions in live rabbits. Br J Ophthalmol. 2021;doi: 10.1136/bjophthalmol-2021-319427.
Hoang, Q. V., Wen, Q., Paik, D. C., Chun, Y. Y., Silverman, R., Nagasaki, T., Trokel, S. L., & Zyablitskaya, M. (2021). Scleral growth stunting via sub-Tenon injection of cross-linking solutions in live rabbits. The British journal of ophthalmology, . https://doi.org/10.1136/bjophthalmol-2021-319427
Hoang, Quan V, et al. "Scleral growth stunting via sub-Tenon injection of cross-linking solutions in live rabbits." The British journal of ophthalmology vol. (2021). doi: https://doi.org/10.1136/bjophthalmol-2021-319427
Hoang QV, Wen Q, Paik DC, Chun YY, Silverman R, Nagasaki T, Trokel SL, Zyablitskaya M. Scleral growth stunting via sub-Tenon injection of cross-linking solutions in live rabbits. Br J Ophthalmol. 2021 Oct 20; doi: 10.1136/bjophthalmol-2021-319427. Epub 2021 Oct 20. PMID: 34670748.
Copy Download .nbib Format: NLM
Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission?.

Microorganisms

Petrillo F, Chianese A, De Bernardo M, Zannella C, Galdiero M, Reibaldi M, Avitabile T, Boccia G, Galdiero M, Rosa N, Franci G.
PMID: 34442628
Microorganisms. 2021 Jul 21;9(8). doi: 10.3390/microorganisms9081550.

In 2020, a global pandemic was declared following the spread of SARS-CoV-2, the pathogen responsible for COVID-19. The risk of infection is high due to the ease of transmission, which can occur orally, through droplets, or via contact with...

Cite
Petrillo F, Chianese A, De Bernardo M, et al. Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission?. Microorganisms. 2021;9(8)doi: 10.3390/microorganisms9081550.
Petrillo, F., Chianese, A., De Bernardo, M., Zannella, C., Galdiero, M., Reibaldi, M., Avitabile, T., Boccia, G., Galdiero, M., Rosa, N., & Franci, G. (2021). Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission?. Microorganisms, 9(8), . https://doi.org/10.3390/microorganisms9081550
Petrillo, Francesco, et al. "Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission?." Microorganisms vol. 9,8 (2021). doi: https://doi.org/10.3390/microorganisms9081550
Petrillo F, Chianese A, De Bernardo M, Zannella C, Galdiero M, Reibaldi M, Avitabile T, Boccia G, Galdiero M, Rosa N, Franci G. Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission?. Microorganisms. 2021 Jul 21;9(8). doi: 10.3390/microorganisms9081550. PMID: 34442628; PMCID: PMC8401441.
Copy Download .nbib Format: NLM
Contamination of multi dose eyedrops in the intra and perioperative context.

Scientific reports

Daehn T, Schneider A, Knobloch J, Hellwinkel OJC, Spitzer MS, Kromer R.
PMID: 34645913
Sci Rep. 2021 Oct 13;11(1):20364. doi: 10.1038/s41598-021-99892-8.

In this study, we examined the rate of contamination of multi-dose ophthalmic solutions in the operating theatre and the underlying risk for infection by examining the microbiological load on the tips of the dispenser bottles. A total of 245...

Cite
Daehn T, Schneider A, Knobloch J, et al. Contamination of multi dose eyedrops in the intra and perioperative context. Sci Rep. 2021;11(1):20364doi: 10.1038/s41598-021-99892-8.
Daehn, T., Schneider, A., Knobloch, J., Hellwinkel, O. J. C., Spitzer, M. S., & Kromer, R. (2021). Contamination of multi dose eyedrops in the intra and perioperative context. Scientific reports, 11(1), 20364. https://doi.org/10.1038/s41598-021-99892-8
Daehn, Tristan, et al. "Contamination of multi dose eyedrops in the intra and perioperative context." Scientific reports vol. 11,1 (2021): 20364. doi: https://doi.org/10.1038/s41598-021-99892-8
Daehn T, Schneider A, Knobloch J, Hellwinkel OJC, Spitzer MS, Kromer R. Contamination of multi dose eyedrops in the intra and perioperative context. Sci Rep. 2021 Oct 13;11(1):20364. doi: 10.1038/s41598-021-99892-8. PMID: 34645913; PMCID: PMC8514486.
Copy Download .nbib Format: NLM
Persistent Corneal Epithelial Defects: A Review Article.

Medical hypothesis, discovery & innovation ophthalmology journal

Vaidyanathan U, Hopping GC, Liu HY, Somani AN, Ronquillo YC, Hoopes PC, Moshirfar M.
PMID: 31598519
Med Hypothesis Discov Innov Ophthalmol. 2019;8(3):163-176.

Persistent corneal epithelial defects (PEDs or PCEDs) result from the failure of rapid re-epithelialization and closure within 10-14 days after a corneal injury, even with standard supportive treatment. Disruptions in the protective epithelial and stromal layers of the cornea...

Cite
Vaidyanathan U, Hopping GC, Liu HY, et al. Persistent Corneal Epithelial Defects: A Review Article. Med Hypothesis Discov Innov Ophthalmol. 2019;8(3):163-176
Vaidyanathan, U., Hopping, G. C., Liu, H. Y., Somani, A. N., Ronquillo, Y. C., Hoopes, P. C., & Moshirfar, M. (2019). Persistent Corneal Epithelial Defects: A Review Article. Medical hypothesis, discovery & innovation ophthalmology journal, 8(3), 163-176.
Vaidyanathan, Uma, et al. "Persistent Corneal Epithelial Defects: A Review Article." Medical hypothesis, discovery & innovation ophthalmology journal vol. 8,3 (2019): 163-176.
Vaidyanathan U, Hopping GC, Liu HY, Somani AN, Ronquillo YC, Hoopes PC, Moshirfar M. Persistent Corneal Epithelial Defects: A Review Article. Med Hypothesis Discov Innov Ophthalmol. 2019;8(3):163-176. PMID: 31598519; PMCID: PMC6778469.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 78 entries